Seed Our Future receives the 2025 GreenShield Award for a decade of advocacy, community support and responsible leadership led by Guy and Hellen Coxall across the UK.

Intractable receives the 2025 GreenShield Award for their leadership in advocacy, public support and sector wide progress for families affected by intractable epilepsy.

Dalgety is recognised with the 2025 GreenShield Award for leading UK cannabis education, uniting sector organisations and expanding public understanding of cannabinoid medicine.

The Cannabis Trades Association is honoured with the 2025 GreenShield Award for a decade of leadership, advocacy and industry support across the UK cannabis sector.

Over the past year, Lyphe Clinic has undertaken one of the most ambitious internal education initiatives of any medical cannabis provider in the UK. At a time when the sector still struggles with fragmented knowledge, inconsistent training, and a lack of shared scientific frameworks, Lyphe took a decisive step: They became one of the first clinics in the country to implement a unified, standardised cannabis literacy framework across their entire team.

The GreenShield Awards highlight those who have shown leadership in many different ways. Some have strengthened patient care, some have contributed to community or charitable initiatives, some have invested in literacy and safety, and others have helped raise standards across the wider sector. Each winner is unique, and each has made a meaningful difference.

UK medical cannabis prescribing remains below 1 percent. This article examines the scientific and regulatory barriers behind this gap, including trial limitations, real-world evidence, ECS variability, and systemic challenges. A must-read for anyone interested in cannabinoid science, medical innovation, and the future of UK healthcare.

We’ve officially declassified the UK’s first ECS Induction Program — a pioneering digital training designed to put the science of the Endocannabinoid System (ECS) directly into the hands of those shaping the future of cannabis medicine.

The ACMD and GPhC 2025 reports reveal major governance and training gaps across the UK’s medical cannabis system. Our new article explores these findings — and how GCS’s science-led CPD Ecosystem is delivering the solutions clinics and pharmacies need.

Global Cannabinoid Solutions (GCS) supports Medical Cannabis Awareness Month 2025 — the UK’s largest collaborative education campaign on cannabinoid medicine. Discover The Science Behind the Stories, our four-part series supporting Intractable and End Our Pain.

Pressure is mounting on the Trump administration from both sides of the aisle to take a definitive stance on cannabis policy, especially as two pivotal US Supreme Court cases near the docket, potentially forcing the administration’s hand.

Training staff to navigate cannabinoids, pharmaceuticals, and patient complexities is no longer a “nice-to-have.” It’s essential. Yet most clinics are stuck trying to self-educate in a field changing faster than they can manage.